Risedronate
Mostrando 1-5 de 5 artigos, teses e dissertações.
-
1. Diretrizes para prevenção e tratamento da osteoporose induzida por glicocorticoide
Os glicocorticoides (GC) são prescritos por praticamente todas as especialidades médicas, e cerca de 0,5% da população geral do Reino Unido utiliza esses medicamentos. Com o aumento da sobrevida dos pacientes com doenças reumatológicas, a morbidade secundária ao uso dessa medicação representa um aspecto importante que deve ser considerado no manejo
Revista Brasileira de Reumatologia. Publicado em: 2012-08
-
2. Alendronate of sodium, risedronate of sodium atorvastatin calcic and lovastatin in tibiais fractures in female rats with dexamethasone osteoporosis induced / Alendronato de sódio, risedronato sódico, atorvastatina cálcica e lovastatina na reparação de fraturas tibiais em ratas com osteoporose induzida pela dexametasona
This work consisted of a biological test with the objective to study the influences of the bifosfonates alendronate of sodium and sodic risedronate and of the statins calcic atorvastatine and lovasatatine in the recuperation of fractures of shin-bones of osteoporotics rats induced by the dexamethasone, in rats of the race Wistar, adults, weighing 250 20g. Th
Publicado em: 2007
-
3. Antiresorptive Effects of Phytoestrogen Supplements Compared with Estradiol or Risedronate in Postmenopausal Women Using 41Ca Methodology
Introduction: Reduction of ovarian estrogen secretion at menopause increases net bone resorption and leads to bone loss. Isoflavones have been reported to protect bone from estrogen deficiency, but their modest effects on bone resorption have been difficult to measure with traditional analytical methods.
The Endocrine Society.
-
4. In Vivo Activities of Farnesyl Pyrophosphate Synthase Inhibitors against Leishmania donovani and Toxoplasma gondii
The in vivo activities of three bisphosphonates were determined against Leishmania donovani and Toxoplasma gondii. Alendronate was essentially inactive against both parasites. Pamidronate was active against L. donovani by intravenous administration. Risedronate had a 50% effective dosage of five 2.6-mg/kg of body weight intraperitoneal doses against L. donov
American Society for Microbiology.
-
5. Current and potential future drug treatments for osteoporosis.
There has been a major interest in the drug treatment of osteoporosis and an increase in the number of drugs available in most countries. The ideal drug (one which increases or restores bone density and trabecular connectivity) is still not available. However, in patients with relatively preserved trabecular connectivity and moderately reduced bone density,